Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The complement system plays a paradoxical role in the development and expression of autoimmunity in humans. The activation of complement in systemic lupus erythematosus (SLE) contributes to tissue injury. In contrast, inherited deficiency of classical pathway components, particularly C1q (ref. 1), is powerfully associated with the development of SLE. This leads to the hypothesis that a physiological action of the early part of the classical pathway protects against the development of SLE (ref. 2) and implies that C1q may play a key role in this respect. C1q-deficient (C1qa-/-) mice were generated by gene targeting and monitored for eight months. C1qa-/- mice had increased mortality and higher titres of autoantibodies, compared with strain-matched controls. Of the C1qa-/- mice, 25% had glomerulonephritis with immune deposits and multiple apoptotic cell bodies. Among mice without glomerulonephritis, there were significantly greater numbers of glomerular apoptotic bodies in C1q-deficient mice compared with controls. The phenotype associated with C1q deficiency was modified by background genes. These findings are compatible with the hypothesis that C1q deficiency causes autoimmunity by impairment of the clearance of apoptotic cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Casciola-Rosen, L. A., Anhalt, G., & Rosen, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1317 · Cited by 1,717
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Casciola-Rosen, L., Rosen, A., Petri, M., & Schlissel, M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1624 · Cited by 482
Baker, A. J., Mooney, A., Hughes, J., Lombardi, D., Johnson, R. J., & Savill, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117565 · Cited by 404
LeFeber, W. P., Norris, D. A., Ryan, S. R., Huff, J. C., Lee, L. A., Kubo, M., Boyce, S. T., Kotzin, B. L., & Weston, W. L. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111569 · Cited by 335
Complement deficiency and disease
Morgan, B. P., & Walport, M. J. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90003-c · Cited by 302
Self-citationNovel packages of viral and self-antigens are generated during apoptosis.
Rosen, A., Casciola-Rosen, L., & Ahearn, J. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1557 · Cited by 246
Hereditary C1q deficiency and systemic lupus erythematosus
(1994) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068955 · Cited by 207
Self-citationGolan, T. D., Elkon, K. B., Gharavi, A. E., & Krueger, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115922 · Cited by 165
Subnucleosome structures as substrates in enzyme-linked immunosorbent assays
Burlingame, R. W., & Rubin, R. L. (1990) · Journal of Immunological Methods · doi:10.1016/0022-1759(90)90380-e · Cited by 124
Cited by
Items 601–700 of 1,000
ABCA1 and the engulfment of apoptotic cells
Hamon, Y., Chambenoit, O., & Chimini, G. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00325-6 · Cited by 64
Fernandez-Castaneda, A., Arandjelovic, S., Stiles, T. L., Schlobach, R. K., Mowen, K. A., Gonias, S. L., & Gaultier, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384693 · Cited by 55
“lar environment, generating an inflammatory stimulus that could lead to the development of autoimmune diseases, including MS (3, 43).”
BackgroundRecent Developments in the Role of High-Mobility Group Box 1 in Systemic Lupus Erythematosus
Schaper, F., Westra, J., & Bijl, M. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00019 · Cited by 55
“In several animal models, deficiency of proteins such as complement factor C1q and serum amyloid P component (SAP), which are involved in opsonization and thereby phagocytosis and clearance of apoptotic cells, results in spontaneous development of lupuslike features, including production of autoantibodies and prolifer…”
BackgroundNatural antibody and complement activation characterize patients with idiopathic nephrotic syndrome
Trachtman, H., Laskowski, J., Lee, C., Renner, B., Feemster, A., Parikh, S. M., Panzer, S. E., Zhong, W., Cravedi, P., Cantarelli, C., et al. (2021) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00041.2021 · Cited by 55
Immune complex processing in C1q-deficient mice
Nash, J. T., Taylor, P. R., Botto, M., Norsworthy, P. J., Davies, K. A., & Walport, M. J. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01459.x · Cited by 61
Self-citationWhat do mouse models teach us about human SLE?
Liu, K., & Mohan, C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.01.014 · Cited by 59
Complement mediated cell death is associated with DNA fragmentation
Cragg, M. S., Howatt, W. J., Bloodworth, L., Anderson, V. A., Morgan, B. P., & Glennie, M. J. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400627 · Cited by 55
Susceptibility genes in the pathogenesis of murine lupus.
Nguyen, C., Limaye, N., & Wakeland, E. K. (2002) · Arthritis Research · doi:10.1186/ar583 · Cited by 55
“The first component of the complement pathway, C1q, leads to the development of autoimmunity when it is disrupted in the mouse.”
BackgroundInfluentialNatural autoantibodies and associated B cells in immunity and autoimmunity
Mannoor, K., Xu, Y., & Chen, C. (2012) · Autoimmunity · doi:10.3109/08916934.2012.748753 · Cited by 57
Dorward, D. A., Lucas, C. D., Rossi, A. G., Haslett, C., & Dhaliwal, K. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.05.006 · Cited by 57
McCloskey, M., de Lafaille, M. A. C., Carroll, M. C., & Erlebacher, A. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100354 · Cited by 62
“C1qa/ (Botto et al., 1998), C4/ (Wessels et al., 1995), Cr2/ (Ahearn et al., 1996), and CD11c-DTR (Jung et al., 2002) mice, all on B6 backgrounds, have been previously described.”
BackgroundComplement in glomerular injury
Berger, S. P., & Daha, M. R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0090-3 · Cited by 54
Cellular Regulation of the Inflammatory Response
Janssen, W. J., & Henson, P. M. (2012) · Toxicologic Pathology · doi:10.1177/0192623311428477 · Cited by 50
“Similar findings have been reported in mice prone to autoimmunity (Scott et al. 2001; Hanayama et al. 2004; Kim et al. 2003; Ling, Pi, and Holoshitz 2007; Botto et al. 1998; Heidari et al. 2006).”
ResultModulation of apoptosis as a target for liver disease
Eichhorst, S. T. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.1.83 · Cited by 57
Increased Susceptibility of C1q-Deficient Mice toSalmonella entericaSerovar Typhimurium Infection
Warren, J. A., Mastroeni, P., Dougan, G., Noursadeghi, M., Cohen, J., Walport, M. J., & Botto, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.2.551-557.2002 · Cited by 65
“generated as described previously (4).”
Self-citationGoldbach‐Mansky, R. T., Alehashemi, S., & de Jesus, A. A. (2024) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01184-8 · Cited by 54
“…level, the C1q complex mediates clearance of apoptotic tissue cells; in C1q -knockout mice 222 uncleared apoptotic kidney cells expose chromatin and other self-antigen, triggering local immune complex formation, activation of the terminal membrane attack complex and direct kidney damage 222,223 .”
TAM receptors in apoptotic cell clearance, autoimmunity, and cancer
Nguyen, K.-Q. N., Tsou, W., Kotenko, S. V., & Birge, R. B. (2013) · Autoimmunity · doi:10.3109/08916934.2013.794515 · Cited by 55
“However, while macrophages isolated from SLE patients frequently show defective clearance [7], the identification of the genetic risk factors underscoring these defects is a daunting challenge, as over forty receptors and soluble bridging proteins and even more intracellular adaptor and signaling proteins are implicat…”
BackgroundInfluentialTripi, L. M., Manzi, S., Chen, Q., Kenney, M., Shaw, P., Kao, A. H., Bontempo, F. A., Kammerer, C. M., & Kamboh, M. I. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21889 · Cited by 53
Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression
Georgiev, M., Agle, L. M. A., Chu, J. L., Elkon, K. B., & Ashany, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20759 · Cited by 53
Toubi, E., Kessel, A., Goldstein, L., Slobodin, G., Sabo, E., Shmuel, Z., & Zuckerman, E. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00207-0 · Cited by 53
The Kidney Biopsy in Lupus Nephritis
Rovin, B. H., Parikh, S. V., & Alvarado, A. S. (2014) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2014.04.004 · Cited by 52
Teeling, J. L., Carare, R. O., Glennie, M. J., & Perry, V. H. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0995-3 · Cited by 50
“mice were obtained from Dr Aras Kadioglu (Leicester, UK) with permission from Professor Marina Botto (London, UK) [7].”
MethodOcular Dominance Plasticity in Binocular Primary Visual Cortex Does Not Require C1q
Welsh, C. A., Stephany, C.-É., Sapp, R. W., & Stevens, B. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1011-19.2019 · Cited by 56
“Loss of the C1qa gene is sufficient to disrupt the protein complex and abolish classical complement cascade activation (Botto et al., 1998), and immunoreactivity of the C1q antibody was previously shown to be absent in C1qa / animals (Stephan et al., 2013).”
BackgroundThe Genes of Systemic Autoimmunity
Theofilopoulos, A. N., & Kono, D. H. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99244.x · Cited by 52
Mannoor, K., Matejuk, A., Xu, Y., Beardall, M. K., & Chen, C. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102859 · Cited by 53
Csorba, K., Schirmbeck, L. A., Tuncer, E., Ribi, C., Roux‐Lombard, P., Chizzolini, C., Huynh‐Do, U., Vanhecke, D., & Trendelenburg, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02619 · Cited by 51
“Mice Six to nine week-old C57BL/6N and C1qa female mice (21) with a body weight of approximately 19 g, were obtained from the animal facility of the Department of Biomedicine, where they were maintained under pathogen-free conditions.”
MethodSystemic Lupus Erythematosus and Apoptosis: A Question of Balance
Mevorach, D. (2003) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:25:1:49 · Cited by 56
Hu, C., Wu, C., Tsai, H., Chang, S., Tsai, W., & Hsu, P. (2009) · Lupus · doi:10.1177/0961203309103027 · Cited by 51
Sekine, H., Ruiz, P., Gilkeson, G. S., & Tomlinson, S. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.015 · Cited by 52
“In act, C1q deficient mice have increased mortality and high titers f autoantibodies, with 25% of C1q−/− mice developing glomeruonephritis with glomerular IC deposits and multiple apoptotic odies (Botto et al., 1998).”
BackgroundVogt, B., Führnrohr, B. G., Müller, R., & Sheriff, A. (2007) · Autoimmunity · doi:10.1080/08916930701358925 · Cited by 51
Lipoxins and Annexin-1: Resolution of Inflammation and Regulation of Phagocytosis of Apoptotic Cells
Scannell, M., & Maderna, P. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.259 · Cited by 48
Taylor, P. R., Botto, M., & Walport, M. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70167-8 · Cited by 57
Self-citationRossbacher, J., & Shlomchik, M. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022042 · Cited by 49
The trigger to cell death determines the efficiency with which dying cells are cleared by neighbours
Wiegand, U. K., Corbach, S., Prescott, A. R., Savill, J., & Spruce, B. A. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400867 · Cited by 51
Antibodies and complement are key drivers of thrombosis
Stark, K., Kilani, B., Stockhausen, S., Busse, J., Schubert, I., Tran, T.-D., Gaertner, F., Leunig, A., Pekayvaz, K., Nicolai, L., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.007 · Cited by 54
Nucleosome‐releasing factor: a new role for factor VII‐activating protease (FSAP)
Zeerleder, S., Zwart, B., Velthuis, H., Stephan, F., Manoe, R., Rensink, I., & Aarden, L. (2008) · The FASEB Journal · doi:10.1096/fj.08-110429 · Cited by 64
“Binding of these plasma proteins enables professional phagocytes to recognize and eliminate sn cells (3, 6 – 8). The importance of plasma proteins in the removal of sn cells is illustrated by the fact that a deficiency of IgM or of the early complement components is associated with a defective or delayed clearance of…”
BackgroundUpdate on the cellular and molecular aspects of lupus nephritis
Frangou, E. A., Georgakis, S., & Bertsias, G. K. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108445 · Cited by 51
Development and Selection of Edited B Cells in B6.56R Mice
Sekiguchi, D. R., Yunk, L., Gary, D., Charan, D., Srivastava, B., Allman, D., WEIGERT, M. G., & Prak, E. T. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6879 · Cited by 50
In vivo evidence for apoptosis in the bone marrow in systemic lupus erythematosus
Hepburn, A. L., Lampert, I. A., Boyle, J. J., Horncastle, D. E., Ng, W., Layton, M., Vyse, T. J., Botto, M., & Mason, J. C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065003 · Cited by 50
Self-citationComplement and glomerulonephritis: new insights
Turnberg, D., & Cook, H. T. (2005) · Current Opinion in Nephrology and Hypertension · doi:10.1097/01.mnh.0000165887.75501.24 · Cited by 51
Self-citationCrosstalk between the α2β1 integrin and c-met/HGF-R regulates innate immunity
McCall-Culbreath, K. D., Li, Z., & Zutter, M. M. (2008) · Blood · doi:10.1182/blood-2007-08-107664 · Cited by 46
Interferon γ suppresses glucocorticoid augmentation of macrophage clearance of apoptotic cells
Heasman, S. J., Giles, K. M., Rossi, A. G., Allen, J. E., Haslett, C., & Dransfield, I. (2004) · European Journal of Immunology · doi:10.1002/eji.200324698 · Cited by 58
“For example, the defective phagocytosis of apoptotic cells that is observed in C1q deficiency contributes to the development of systemic lupus erythematosus [ 8 ].”
BackgroundThe role of apoptosis in systemic lupus erythematosus
Salmon, M., & Gordon, C. (1999) · Rheumatology · doi:10.1093/rheumatology/38.12.1177 · Cited by 50
“sequently present antigens derived from them to the immune system [45–47].”
BackgroundCortés-Hernández, J., Fossati‐Jimack, L., Petry, F., Loos, M., Izui, S., Walport, M. J., Cook, H. T., & Botto, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425616 · Cited by 50
Self-citationWerth, V. P., Berlin, J. A., Callen, J. P., Mick, R., & Sullivan, K. E. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19608.x · Cited by 50
New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis
Bijl, M., Limburg, P. C., & Kallenberg, C. G. (2001) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(01)00131-0 · Cited by 56
“The functional impact of these findings has subsequently been demonstrated in mice using selective gene deletion [63-66].”
Kenyon, K. D., Cole, C., Crawford, F., Kappler, J. W., Thurman, J. M., Bratton, D. L., Boackle, S. A., & Henson, P. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003468 · Cited by 49
“Numerous serum proteins, including C1q, IgM, C-reactive protein, and mannan-binding lectin, deposit on apoptotic cells, initiating and amplifying the deposition of C3 and its degradation products C3b and iC3b (5) and resulting in enhanced removal via recognition by complement receptors CR3 and CR4 (4, 6, 7).”
BackgroundComplement Factor D protects mice from ethanol-induced inflammation and liver injury
McCullough, R. L., McMullen, M. R., Sheehan, M. M., Poulsen, K. L., Roychowdhury, S., Chiang, D. J., Pritchard, M. T., Caballeria, J., & Nagy, L. E. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00334.2017 · Cited by 49
“Complement knockout mice were obtained from the following sources: C4 (14) and C1qa (4) were provided by Dr.”
MethodGaipl, U. S., Beyer, T. D., Baumann, I., Voll, R. E., Stach, C. M., Heyder, P., Kalden, J. R., Manfredi, A. A., & i, M. H. (2003) · Immunobiology · doi:10.1078/0171-2985-00217 · Cited by 49
Fossati‐Jimack, L., da Silveira, S. A., Moll, T., Kina, T., Kuypers, F. A., Oldenborg, P., Reininger, L., & Izui, S. (2002) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0563 · Cited by 53
Immune Adherence Revisited: Novel Players in an Old Game
Hess, C., & Schifferli, J. A. (2003) · Physiology · doi:10.1152/nips.01425.2002 · Cited by 58
Khan, T. N., Wong, E. B., Soni, C., & Rahman, Z. S. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200824 · Cited by 54
“ACs such as C1q (C1q) and Tim-4 (Tim-4) all developed autoimmunity (4, 5).”
BackgroundAn update on genetic studies of systemic lupus erythematosus
Tsao, B. P. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0046-5 · Cited by 49
“Furthermore, 50% of the homozygous C1qdeficient mice develop high titer antinuclear antibodies; 25% develop glomerulonephritis with immune deposits [ 26 ].”
BackgroundApoptosis during lymphoid development
Sohn, S. J., Rajpal, A., & Winoto, A. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00004-9 · Cited by 54
The pathophysiology of photosensitivity in lupus erythematosus
Orteu, C. H., Sontheimer, R. D., & Dutz, J. P. (2001) · Photodermatology Photoimmunology & Photomedicine · doi:10.1034/j.1600-0781.2001.170301.x · Cited by 52
“Mice with C1q deficiency develop an SLE-like disease associated with an accumulation of apoptotic cells in the kidney (137).”
BackgroundMartin, D. A., & Elkon, K. B. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21677 · Cited by 49
Gorgani, N. N., Smith, B. A., Kono, D. H., & Theofilopoulos, A. N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4745 · Cited by 53
“Our results indicate that HRG potentiates ingestion of apoptotic cells at a level similar to other plasma proteins, such as C1q (31) and TSP (35).”
BackgroundInfluentialAutoantibodies against complement component C1q in systemic lupus erythematosus
Trendelenburg, M. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1279 · Cited by 48
Role of MHC-Linked Susceptibility Genes in the Pathogenesis of Human and Murine Lupus
Relle, M., & Schwarting, A. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/584374 · Cited by 57
“An association between complement deficiency and SLE has also been shown for complementdeficient mouse models [210].”
BackgroundThe regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation
Mascarell, L., Airouche, S., Berjont, N., Gary, C., Guéguen, C., Fourcade, G., Bellier, B., Togbe, D., Ryffel, B., Klatzmann, D., et al. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.87 · Cited by 48
Macrophagic Stabilin-1 Restored Disruption of Vascular Integrity Caused by Sepsis
Lee, W., Park, S.-Y., Yoo, Y., Kim, S.-Y., Kim, J.-E., Kim, S.-W., Seo, Y.-K., Park, E., Kim, I.-S., & Bae, J.-S. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1669477 · Cited by 45
Pathogenic roles of autoantibodies in systemic sclerosis: Current understandings in pathogenesis
Senécal, J., Hoa, S. A.-T., Yang, R., & Koenig, M. (2019) · Journal of Scleroderma and Related Disorders · doi:10.1177/2397198319870667 · Cited by 53
“83,86 Indeed, in patients with SARDs such as SLE, the normal homeostatic process is overwhelmed by defective clearance of apoptotic cells, 87 leading in turn to secondary necrosis and loss of plasma membrane integrity that result in the release of various aAgs in the tissue microenvironment.”
Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
Li, N. L., Birmingham, D. J., & Rovin, B. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040626 · Cited by 48
“C1qdeficient mice develop high titers of autoantibodies and can develop severe proliferative and crescentic glomerulonephritis, characterized by the presence of glomerular apoptotic bodies, immune deposits, and C3 staining [16,17].”
BackgroundMalik, A., Thanekar, U., Amarachintha, S. P., Mourya, R., Nalluri, S., Bondoc, A. J., & Shivakumar, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.627701 · Cited by 49
Pfueller, B., Wolbart, K., Bruns, A., Burmester, G. R., & Hiepe, F. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200108)44:8<1962::aid-art335>3.0.co;2-r · Cited by 48
Kishore, U., Kojouharova, M. S., & m, R. K. B. (2002) · Immunobiology · doi:10.1078/0171-2985-00138 · Cited by 48
Quigg, R. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3319 · Cited by 51
“A proportion of mice with targeted deletion of C1q developed spontaneous GN (76) and in MRL/Mp / mice, deficiency of C1q accelerated glomerular disease (77).”
BackgroundA Major Linkage Region on Distal Chromosome 4 Confers Susceptibility to Mouse Autoimmune Gastritis
Silveira, P. A., Baxter, A. G., Cain, W. E., & van Driel, I. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5106 · Cited by 48
Genetics of immune-mediated disorders: from genome-wide association to molecular mechanism
Kumar, V., Wijmenga, C., & Xavier, R. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.09.007 · Cited by 48
Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells
Kang, Y.-H., Urban, B. C., Sim, R. B., & Kishore, U. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.10.008 · Cited by 47
Tolerance: an overview and perspectives
Waldmann, H. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.108 · Cited by 54
Kollias, G. A., Kontoyiannis, D. L., Douni, E. K., & Kassiotis, G. (2001) · KARGER eBooks · doi:10.1159/000060546 · Cited by 47
Dean, Y. D., McGreal, E. P., Akatsu, H., & Gasque, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006229200 · Cited by 47
Target Pattern Recognition by Complement Proteins of the Classical and Alternative Pathways
Kang, Y.-H., Tan, L. A., Carroll, M. V., Gentle, M. E., & Sim, R. B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0901-5_8 · Cited by 47
Protection and injury: the differing roles of complement in the development of glomerular injury
Sheerin, N., Springall, T., Abe, K., & Sacks, S. H. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1255::aid-immu1255>3.0.co;2-w · Cited by 48
Ultraviolet-Radiation-Induced Keratinocyte Apoptosis in C1q-Deficient Mice
Pickering, M. C., Fischer, S., Lewis, M., Walport, M. J., Botto, M., & Cook, H. T. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01381.x · Cited by 47
Self-citationHow Does the Brain Limit the Severity of Inflammation and Tissue Injury During Bacterial Meningitis?
Neal, J., & Gasque, P. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182909f2f · Cited by 49
Genomics of Systemic Lupus Erythematosus
Hiraki, L. T., & Silverman, E. D. (2017) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2017.04.005 · Cited by 51
Miura-Shimura, Y., Nakamura, K., Ohtsuji, M., Tomita, H., Jiang, Y., Abe, M., Zhang, D., Hamano, Y., Tsuda, H., Hashimoto, H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1334 · Cited by 46
“C1q proteins also play an important role in the clearance of apoptotic bodies (8, 10, 26).”
BackgroundInfluentialDepboylu, C., Schorlemmer, K., Klietz, M., Oertel, W. H., Weihe, E., Höglinger, G. U., & Schäfer, M. K.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.05.006 · Cited by 47
Development of a specific system for targeting protein to metallophilic macrophages
Taylor, P. R., Zamze, S., Stillion, R. J., Wong, S. Y. C., Gordon, S., & Martinez-Pomares, L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308490100 · Cited by 46
Apoptosis, clearance mechanisms, and the development of systemic lupus erythematosus
Navratil, J. S., & Ahearn, J. M. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0018-1 · Cited by 48
Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system
Mevorach, D. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0530-8 · Cited by 51
“Complement factors were shown to mediate efficient clearance of apoptotic cells via macrophages [55, 56] and the generation of tolerogenic DCs [40].”
BackgroundSarang, Z., Joós, G., Garabuczi, É., Rühl, R., Gregory, C. D., & Szondy, Z. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400284 · Cited by 49
“Increasing evidence suggests that impaired phagocytosis of apoptotic cells caused by the loss of various phagocytic receptors leads to the development of SLE in humans and in mice (5, 7, 8, 12, 16, 18, 30).”
BackgroundPathogenesis of systemic lupus erythematosus (SLE)
Robson, M. G., & Walport, M. J. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01147.x · Cited by 51
Self-citationDNaseI in pathogenesis of systemic lupus erythematosus
Tsukumo, S., & Yasutomo, K. (2004) · Clinical Immunology · doi:10.1016/j.clim.2004.05.009 · Cited by 48
Held, K., Thiel, S., Loos, M., & Petry, F. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.021 · Cited by 45
Self-citationControl of apoptosis in autoimmunity
Maniati, E., Potter, P. K., Rogers, N. J., & Morley, B. J. (2007) · The Journal of Pathology · doi:10.1002/path.2270 · Cited by 57
“C1q knockout mice show elevated levels of apoptotic material in renal tissue and develop glomerulonephritis [81].”
BackgroundComplement in transplant rejection: diagnostic and mechanistic considerations
Baldwin, W. M., Ota, H., & Rodríguez, E. R. (2003) · Springer Seminars in Immunopathology · doi:10.1007/s00281-003-0133-3 · Cited by 46
“This possibility was first suggested by the finding that deficiencies of C1q and C4 are correlated with increased incidences of severe forms of autoimmunity [ 11 , 57].”
BackgroundComplement: Functions, location and implications
Kareem, S., Jacob, A., Mathew, J., Quigg, R. J., & Alexander, J. J. (2023) · Immunology · doi:10.1111/imm.13663 · Cited by 46
Factor H as a regulator of the classical pathway activation
Kishore, U., & Sim, R. B. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.07.024 · Cited by 44
Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus
Hein, E., Nielsen, L. A., Nielsen, C. T., Munthe‐Fog, L., Skjoedt, M., Jacobsen, S., & Garred, P. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.003 · Cited by 44
Predictive value of anti-dsDNA autoantibodies: Importance of the assay
Munoz, L. E., Gaipl, U. S., & i, M. H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.06.003 · Cited by 44
“The C1q knockout mouse develops glomerulonephritis and shows impaired clearance of apoptotic cells [26].”
BackgroundShannon, J. G., Cockrell, D. C., Takahashi, K., Stahl, G. L., & Heinzen, R. A. (2009) · BMC Immunology · doi:10.1186/1471-2172-10-26 · Cited by 44
“MBL/C1q double k/o, MBL/ factorD double k/o and C1q/factorD double k/o mice were generated by interbreeding MBL k/o [32], C1q k/o [33], and factorD k/o [34] mice and maintained at Taconic Farms.”
MethodAnti-C1q autoantibodies in murine lupus nephritis
Trouw, L. A., Seelen, M. A., VISSEREN, R., Duijs, J. M. G. J., Benediktsson, H., de Heer, E., ROOS, A., van Kooten, C., & Daha, M. R. (2003) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02345.x · Cited by 48
Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus
Holers, V. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422820 · Cited by 44
Navratil, J. S., Liu, C., & Ahearn, J. M. (2006) · Immunologic Research · doi:10.1385/ir:36:1:3 · Cited by 46
SAP-less chromatin triggers systemic lupus erythematosus
Paul, E., & Carroll, M. C. (1999) · Nature Medicine · doi:10.1038/9450 · Cited by 44
“In support of this model, C1q-deficient mice develop a lupus-like disease (analogous to humans with C1q or C4 deficiency) featuring elevated titers of anti-nuclear autoantibodies and progressive renal diseas”
BackgroundTrouw, L. A., Seelen, M. A., & Daha, M. R. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00105-6 · Cited by 44
Preeclampsia and the Kidney: Pathophysiology and Clinical Implications
Dines, V. A., Suvakov, S. R., Kattah, A. G., Vermunt, J. V., Narang, K., Jayachandran, M., Hassan, C. A., Norby, A. M., & Garovic, V. D. (2023) · Comprehensive physiology · doi:10.1002/cphy.c210051 · Cited by 57
Metadata
- Authors
- Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J.
- Affiliations
- Imperial College London (GB)
- Institute of Medical Microbiology and Hygiene (DE)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Walport, Mark J.
- Venue
- Nature Genetics
- Published
- 1998-05
- Volume
- 19
- Issue
- 1
- Pages
- 56-59
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2067217824
- Cited by
- 1,434
- References
- 21
- Citations by year
- 2026: 13 · 2025: 15 · 2024: 22 · 2023: 18 · 2022: 27 · 2021: 29 · 2020: 20 · 2019: 39 · 2018: 29 · 2017: 37 · 2016: 27 · 2015: 36 · 2014: 47 · 2013: 39 · 2012: 62
- FWCI
- 49.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- C1q deficiency, glomerulonephritis, apoptotic bodies, systemic lupus erythematosus, classical complement pathway, autoimmunity, autoantibodies, efferocytosis, genetic background effects, immune deposits
- MeSH terms
- Animals, Antibodies, Antinuclear, Autoantigens, Crosses, Genetic, Glomerulonephritis, Homozygote, Kidney Glomerulus, Microscopy, Electron, Complement C1q, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.